SP615INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN CHRONIC HEMODIALYSIS PATIENTS WITH PERMANENT SUBCUTANEOUS CATHETER. EFFECT OF PARICALCITOL AND ATORVASTATIN COMBINED TREATMENT. NCT 1820767. EUDRACT 2011-000249-18.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.